Answers are grounded in this paper and cite their sources.
Learning Objectives After completing this course, the reader will be able to: Enumerate the clinical indications for sorafenib and sunitinib therapy.Describe the mechanism of action and the pharmacokinetics of sorafenib and sunitinib.Analyze the toxicity profile and appraise the therapeutic effects associated with sorafenib and sunitinib. This article is available for continuing medical education credit at CME.TheOncologist.com.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: